Table 2.
Clinical presentation of study groups
| Clinical presentation | HIV/HTLV-1, n(%) (n = 29) |
HIV, n(%) (n = 59) |
p value* |
|---|---|---|---|
| Assymptomatic | 7 (24.1) | 14 (23.7) | |
| Papular pruritic eruptions | 3 (10.3) | 14 (23.7) | |
| Dermatitis | 2 (6.9) | 2 (3.4) | |
| Seborrhoeic dermatitis | 2 (6.9) | 0 (0.0) | |
| Folliculitis | 0 (0.0) | 1 (1.7) | |
| Herpes zoster < 5 years | 3 (10.3) | 4 (6.8) | 0.570 |
| TInea capitis | 5 (17.2) | 8 (13.6) | |
| Candidiasis | 3 (10.3) | 4 (6.8) | |
| Tuberculosis < 1 year | 1 (3.5) | 4 (6.8) | |
| Weight loss > 10% | 3 (10.3) | 7 (11.9) | |
| Chronic diarrhoea | 0 (0.0) | 1 (1.7) |
* Fisher chi square test